|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 11727401.9 (espacenet) (Federated) (European Patent Register), 20110621 | Patent/reg. no. and date | DK/EP 2582714, 20170510 | Publication date | 20130424 | Priority no. and date | WO PCT/EP2010/003729, 20100621 | EP pub. no. and date |
EP 2582714 20130424 | Effective date | | Applicant/owner | Xigen Inflammation Ltd., Arch. Makariou III 195 Neocleous House
3030 Limassol, CY | Applicant ref. no. | 160738 | Inventor | BONNY, Christophe, 37c chemin du Trabandan
CH-1006 Lausanne, CH | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | C07K 14/47 (2006.01) , C07K 7/06 (2006.01) , G01N 33/53 (2006.01) | Title | NYE JNK-INHIBITORMOLEKYLER | Int. application no. | EP2011003074 | Int. publication no. | WO2011160827 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |